Loss of heterozygosity at loci from chromosome arm 22Q in human sporadic breast carcinomas

International Journal of Cancer

Volumn 75, Issue 2, 1998, Pages 181-186

  Allione, Florence ^a   Eisinger, François ^a   Parc, Patricia ^a   Noguchi, Tetsuro ^a   Sobol, Hagay ^a   Birnbaum, Daniel ^a,b  

^a INSTITUT PAOLI CALMETTES   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GENETICS; CHROMOSOME 22Q; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 22; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED;

EID: 0032545728     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980119)75:2<181::AID-IJC3>3.0.CO;2-Q     Document Type: Article

References (27)

1. AKAGI, K., KURAHASHI, H., ARITA, N., HAYAKAWA, T., MONDEN, M., MORI, T., TAKAI, S.I. and NISHISHO, I., Deletion mapping of the long arm of chromosome 22 in human meningiomas. Int. J. Cancer, 60, 178-182 (1995).
2. BIÈCHE, I. and LIDEREAU, R., Genetic alterations in breast cancer. Genes Chromosomes Cancer, 14, 227-251 (1995).
3. BIEGEL, J.A., ALLEN, C.S., KAWASAKI, K., SHIMIZU, N., BUDARF, M.L. and BELL, C.J., Narrowing the critical region for a rhabdoid tumor locus in 22q11. Genes Chromosomes Cancer, 16, 94-105 (1996).
4. BRYAN, E., WATSON, R.H., DAVIS, M., HITCHCOCK, A., FOULKES, W. and CAMPBELL, I.G., Localization of an ovarian-cancer tumor-suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q. Cancer Res., 56, 714-721 (1996).
5. DEVILEE, P. and CORNELISSE, C., Somatic genetic changes in human breast cancer. Biochem. biophys. Acta. 1198, 113-130 (1994).
6. DIB, C. and 13 OTHERS, A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (Lond.), 380, 152-154 (1996).
7. ENGLEFIFLD, P., FOULKES, W.D. and CAMPBELL, I.G., Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12. Brit. J. Cancer. 70, 905-907 (1994).
8. GYAPAY, G., MORISSETTE, J., VIGNAL, A., DIB, C., FIZAMES, C., MILLASSEAU, P., MARC, S., BERNARDI, G., LATHROP, M. and WEISSENBACH, J., The 1992-94 Généthon human genetic linkage map. Nature Genet., 7, 246-339 (1994).
9. HARADA, T., IRVING, R.M., XUEREB, J.H., BARTON, D.E., HARDY, D.G., MOFFAT, D.A. and MAHER, E.R., Molecular genetic investigation of the neurofibromatosis type-2 tumor-suppressor gene in sporadic meningioma. J. Neurosurg., 84, 847-851 (1996).
10. HOANG-XUAN, K., MEREL, P., VEGA, F., HUGOT, J.P., CORNU, P., DELATTRE, J.Y., POISSON, M., THOMAS, G. and DELATTRE, O., Analysis of the NF2 tumor-suppressor gene and of chromosome 22 deletions in gliomas. Int. J. Cancer, 60, 478-481 (1995).
11. KANAI, Y., TSUDA, H., ODA, T., SAKAMOTO, M. and HIROHASHI, S., Analysis of the neurofibromatosis-2 gene in human breast and hepatocellular carcinomas. Jap. J. clin. Oncol., 25, 1-4 (1995).
12. KERANGUEVEN, F., ALLIONE, F., NOGUCHI, T., ADELAÏDE, J., SOBOL, H., JACQUEMIER, J. and BIRNBAUM, D., Patterns of loss of heterozygosity at loci from chromosome arm 13q suggest a possible involvement of BRCA2 in sporadic breast tumors. Genes Chromosomes Cancer, 13, 271-274 (1995).
13. LARSSON, C., BRYSTRÖM, C., SKOOG, L., ROTSTEIN, S. and NORDENSKJÖLD, M., Genomic alterations in human breast carcinomas. Genes Chromosomes Cancer, 2, 191-197 (1990).
14. MARINEAU, C., AUBRY, M., JULIEN, J.P. and ROULEAU, G.A., Dinucleotide repeat polymorphism at the D22S264 locus. Nucleic Acids Res., 20, 1430 (1992).
15. NG, H.K., LAU, K.M., TSE, J.Y., LO, K.W., WONG, J.H., POON, W.S. and HUANG, D.P., Combined molecular genetic studies of chromosome 22q and the neurofibromatosis-type-2 gene in central-nervous-system tumors. Neurosurgery, 37, 764-773 (1995).
16. PAPI, L., DE VITIS, L.R., VITELLI, F., AMMANNATI, F., MENNONNA, P., MONTALI, E. and BIGOZZI, U., Somatic mutations in the neurofibromatosistype-2 gene in sporadic meningiomas. Hum. Genet., 95, 347-351 (1995).
17. RASIO, D., NEGRINI, M., MANENTI, G., DRAGANI, T. and CROCE, C., Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions. Cancer Res., 55, 3988-3991 (1995).
18. RUTTLEDGE, M.H., XIE, Y.-G., HAN, F.-Y., PEYRARD, M., COLLINS, P., NORDENSKJÖLD, M. and DUMANSKI, J.P., Deletions on chromosome 22 in sporadic meningioma. Genes Chromosomes Cancer, 10, 122-130 (1994).
19. SCAMBLER, P., Report of the fourth international workshop on human chromosome 22 mapping 1994. Cytogenet. Cell Genet., 67, 278-294 (1994).
20. SCHOFIELD, D., BECKWITH, B. and SKLAR, J., Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors. Genes Chromosomes Cancer, 15, 10-17 (1996).
21. SHIN, E., FUJITA, S., TAKAMI, K., KURAHASHI, H., KURITA, Y., KOBAYASHI, T., MORI, T., NISHISHO, I. and TAKAI, S., Deletion mapping of chromosome 1p and 22q in pheochromocytoma. Jap. J. Cancer Res., 84, 402-408 (1993).
22. TAKAHASHI, K., KUDO, J., ISHIBASHI, H., HIRATA, Y. and NIHO, Y., Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology, 17, 794-799 (1991).
23. TWIST, E.C., RUTTLEDGE, M.H., ROUSSEAU, M., SANSON, M., PAPI, L., MEREL, P., DELATTRE, O., THOMAS, G. and ROULEAU, G.A., The neurofibromatosis-type-2 gene is inactivated in schwannomas. Hum. mol. Genet., 3, 147-151 (1994).
24. VERSTEEG, R., CARON, H., CHENG, N.C., VAN DER DRIFT, P., SLATER, R., WESTERVELD, A., VOUTE, P., DELATTRE, O., LAURKYS, G., VAN ROY, N. and SPELEMAN, F., 1p36: every sub-hand a suppressor? Europ. J. Cancer, 31A, 541-544 (1995).
25. WATKINS, D., RUTTLEDGE, M.H., SARRAZIN, J., RANGARATNAM, S., POISSON, M., DELATTRE, J.Y. and ROULEAU, G.A., Loss of heterozygosity on chromosome 22 in human gliomas does not inactivate the neurofibromatosistype-2 gene. Cancer Genet. Cytogenet., 92, 73-78 (1996).
26. YAEGASHI, S., SACHSE, R., OHUCHI, N., MORI, S. and SEKIYA, T., Low incidence of a nucleotide-sequence alteration of the neurofibromatosis-2 gene in human breast cancers. Jap. J. Cancer Res., 86, 929-933 (1995).
27. YANA, I., KURAHASHI, H., NAKAMORI, S., KAMEYANA, M., NAKAMURA, T., TAKAMI, M., MORI, T., TAKAI, S.I. and NISHISHO, I., Frequent loss of heterozygosity at telomeric loci on 22q in sporadic colorectal cancers. Int. J. Cancer, 60, 174-177 (1995).